These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10759696)

  • 1. Binding of propofol to blood components.
    Suarez E; Calvo R; Zamacona MK; Lukas J
    Br J Clin Pharmacol; 2000 Apr; 49(4):380-1. PubMed ID: 10759696
    [No Abstract]   [Full Text] [Related]  

  • 2. What is the ke0 and what does it tell me about propofol?
    Cortínez LI
    Anaesthesia; 2014 May; 69(5):399-402. PubMed ID: 24738794
    [No Abstract]   [Full Text] [Related]  

  • 3. Propofol concentrations during the anhepatic phase of living-related donor liver transplantation.
    Takizawa D; Hiraoka H; Nakamura K; Yamamoto K; Horiuchi R
    Clin Pharmacol Ther; 2004 Dec; 76(6):648-9. PubMed ID: 15592336
    [No Abstract]   [Full Text] [Related]  

  • 4. Propofol effect-site concentrations: hunt the k(e0).
    Glen JB
    Anesth Analg; 2013 Aug; 117(2):535-6. PubMed ID: 23881380
    [No Abstract]   [Full Text] [Related]  

  • 5. Onset and offset pharmacodynamics of propofol.
    O'Halloran PL; Hosseini-Yeganeh M; McBride LJ; Ramzan I
    Pharmazie; 2004 Jan; 59(1):76-7. PubMed ID: 14964429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propofol pharmacokinetics and pharmacodynamics assessed from a cremophor EL formulation.
    Dutta S; Matsumoto Y; Ebling WF
    J Pharm Sci; 1997 Aug; 86(8):967-9. PubMed ID: 9269876
    [No Abstract]   [Full Text] [Related]  

  • 7. Brain and blood concentrations of propofol after rapid intravenous injection in sheep, and their relationships to cerebral effects.
    Ludbrook GL; Upton RN; Grant C; Gray EC
    Anaesth Intensive Care; 1996 Aug; 24(4):445-52. PubMed ID: 8862641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Required decrement time to predict time of awaking in effect-site concentration can be estimated by using that in predicted blood concentration displayed on the commercial TCI pump.
    Kunisawa T; Onodera Y; Kurosawa A; Sasakawa T; Hanada S; Iwasaki H
    J Anesth; 2010 Dec; 24(6):972-3. PubMed ID: 20936483
    [No Abstract]   [Full Text] [Related]  

  • 9. [Using of chromatographical methods to study stability, pharmacokinetics and metabolism of propofol (review)].
    Adeishvili-Anguladze LV; Makharadze RV; Kurtsikidze MSh; Abuladze NB; Gabuniia KU
    Georgian Med News; 2009 May; (170):95-100. PubMed ID: 19556652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of haemorrhage on plasma propofol concentrations in a patient undergoing orthotopic liver transplantation.
    Turner RJ; Kam PC; Ramzan I; Santilli MB
    Br J Anaesth; 1999 Aug; 83(2):346-8. PubMed ID: 10618958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term stability of propofol in human plasma and blood in different storage conditions.
    Bienert A; Zaba Z; Dyderski S; Ogrodowicz M; Drobnik L
    Acta Pol Pharm; 2005; 62(2):95-7. PubMed ID: 16161348
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma concentration for optimal sedation and total body clearance of propofol in patients after esophagectomy.
    Takizawa D; Sato E; Nishikawa K; Hinohara H; Hiraoka H; Saito S; Goto F; Kunimoto F
    J Anesth; 2005; 19(1):88-90. PubMed ID: 15674525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of propofol in low-volume samples by high-performance liquid chromatography with fluorescence detection.
    Knibbe CA; Koster VS; Deneer VH; Stuurman RM; Kuks PF; Lange R
    J Chromatogr B Biomed Sci Appl; 1998 Mar; 706(2):305-10. PubMed ID: 9551817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TCI: supplementation and drug interactions.
    Vuyk J
    Anaesthesia; 1998 Apr; 53 Suppl 1():35-41. PubMed ID: 9640113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of propofol during liver transplantation in small pigs].
    Mashimo T; Tsuda Y; Ikeda M; Shibuya H; Inagaki Y; Seto T; Yoshiya I
    Masui; 1996 Mar; 45(3):293-7. PubMed ID: 8721126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPLC investigation of free and bound propofol in human plasma and cerebrospinal fluid.
    Dawidowicz AL; Kalityński R
    Biomed Chromatogr; 2003 Oct; 17(7):447-52. PubMed ID: 14598328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fospropofol assay issues and impact on pharmacokinetic and pharmacodynamic evaluation.
    Shah A; Mistry B; Gibiansky E; Gibiansky L
    Anesth Analg; 2009 Jan; 108(1):382; author reply 382-3. PubMed ID: 19095885
    [No Abstract]   [Full Text] [Related]  

  • 18. Tissue/blood and tissue/water partition coefficients for propofol in sheep.
    Weaver BM; Staddon GE; Mapleson WW
    Br J Anaesth; 2001 May; 86(5):693-703. PubMed ID: 11575347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A physiological model of induction of anaesthesia with propofol in sheep. 1. Structure and estimation of variables.
    Upton RN; Ludbrook GL
    Br J Anaesth; 1997 Oct; 79(4):497-504. PubMed ID: 9389270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case of Delayed Emergence After Propofol Anesthesia: Genetic Analysis.
    Yonekura H; Murayama N; Yamazaki H; Sobue K
    A A Case Rep; 2016 Dec; 7(11):243-246. PubMed ID: 27749294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.